Produkty 2465-11-4

CAS 2465-11-4 występuje w naszej ofercie pod nazwami: Stellasterol, >95% (HPLC), Stellasterol. Oferty producentów: TRC, Biosynth, MedChemExpress. Dostępne opakowania: 250mg, 25mg, 10mg, 5mg, 50mg, 100mg, 5 mg.

Stellasterol, >95% (HPLC)
TRC
  • opakowanie: 250mg, 25mg
  • Warianty: 2
Zobacz produkt
Stellasterol
Biosynth, MedChemExpress
  • opakowanie: 10mg, 5mg, 25mg, 50mg
  • Warianty: 6
od 1513,20
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (CAS 2465-11-4) to związek chemiczny o wzorze sumarycznym C28H46O i masie molowej 398.7 g/mol. Nazwa systematyczna IUPAC: (3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol. InChIKey: QOXPZVASXWSKKU-UEIWAABPSA-N.

Dane identyfikacyjne
Wzór sumarycznyC28H46O
Masa molowa398.7 g/mol
Nazwa IUPAC(3S,5S,9R,10S,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChIKeyQOXPZVASXWSKKU-UEIWAABPSA-N
SMILESC[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Stellasterol, Stellasterin, 5-Dihydroergosterol, alpha-Dihydroergosterol, (3beta,5alpha,22E)-Ergosta-7,22-dien-3-ol, 5alpha-Ergosta-7,22-dien-3beta-ol, Ergosterol, alpha-dihydro-, (22e)-5alpha-ergosta-7,22-dien-3beta-ol, Ergosta-7,22-dien-3-ol, (3beta,5alpha,22E)-, 5alpha-ergosta-7,22E-dien-3beta-ol
Izomery (ten sam wzór sumaryczny)
(3S,9S,10R,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5S)-5,6-dimethylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C28H46O
(3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-5-methylidene-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
(3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
trans-(1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol C28H46O
(4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C28H46O
4,10,13-trimethyl-17-(6-methylheptan-2-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C28H46O
(3S,4S,5S,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O
(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H46O